We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,545

Food Addiction Beliefs Drive Support for Obesity-Related Initiatives
  • Shook Hardy & Bacon LLP
  • USA
  • January 29 2016

New research reportedly suggests that belief in food addiction translates into support for obesity-related policies, “even when accounting for the


Avon shareholders reject request to “ditch toxic cosmetics”
  • Shook Hardy & Bacon LLP
  • USA
  • May 10 2013

According to a Securities and Exchange Commission report, Avon Products, Inc. shareholders have rejected a proposal filed by Green Century Equity


FDA steps up issuance of warning letters to cosmetic and dietary supplement companies
  • Shook Hardy & Bacon LLP
  • USA
  • April 1 2015

The Food and Drug Administration (FDA) has issued a number of Warning Letters to cosmetic and dietary supplement companies over the last several


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning


Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


New study questions BPA link to preterm births
  • Shook Hardy & Bacon LLP
  • USA
  • September 4 2015

A study examining increased preterm birth rates in the United States has found "little evidence of a relationship been BPA bisphenol A and


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Chipotle Targeted in Federal Investigations, Shareholder Suit Filed in New York Federal Court
  • Shook Hardy & Bacon LLP
  • USA
  • January 8 2016

Chipotle Mexican Grill has reportedly been served with a grand jury subpoena as part of a U.S. Attorney's Office and Food and Drug Administration


Claudia Kalb, “Culture of Corpulence,” Newsweek, March 22, 2010
  • Shook Hardy & Bacon LLP
  • USA
  • March 19 2010

This article invokes public-health campaigns of the past, including measures taken to increase seat belt use and stop drunk driving, to call for "big-think solutions" to the nation's obesity problems


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs